Cgamp

Cgamp has been studied in 3 papers since 2023: none in people yet, 3 in animals; 2 in the past year. The research so far is in animals. The newest story, Oct 2, 2026: “Extracellular cGAMP drives neuroinflammation and premature aging phenotypes in mice”.

InterventionPreclinical

3 papers study it37 more mention it3 findingsUpdated

PubChemChEBI

3 new papers in 30 daysSee all 40 papers on cgamp

At a glance

The findings reach mice, none yet in people. 2 independent labs in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 2 independent labs in 1 country
  • 2 of 3 findings with company ties
  • Animals3

What did studies of cgamp find?

3

Studies of cgamp measured 3 outcomes: interferon-stimulated gene induction, type I interferon signaling and influenza.

interferon-stimulated gene induction

upin mice1

1 study
  1. Cgamp activates interferon-stimulated gene induction in mice (STING-dependent, in microglia, astrocytes and inhibitory neurons).

    “microglia, astrocytes, and inhibitory neurons as the principal cGAMP responders that activate STING-dependent interferon-stimulated gene induction in response to elevated extracellular cGAMP”

    AnimalsSTING-dependent, in microglia, astrocytes and inhibitory neurons

    Extracellular cGAMP drives neuroinflammation and premature aging phenotypes in mice

    bioRxivPreprint

Type I interferon signaling

upin mice1

1 study
  1. Cgamp induces type I interferon signaling in mice.

    “A single dose of NanoSTING administered intranasally induced robust type I interferon responses in the nasal and lung tissue of mice without observable toxicity.”

    Animalsliposomally encapsulated cGAMPnasal and lung tissue

    Therapeutic intranasal delivery of NanoSTING provides broad protection against seasonal and highly pathogenic influenza strains

    Antiviral research

More on Type I interferon signaling

Influenza

downin mice1

1 study
  1. Cgamp protects against influenza in mice (mouse challenge models of influenza A (H1N1 or highly pathogenic H5N1) and influenza B).

    “NanoSTING provided therapeutic protection at least as effective as ten doses of oseltamivir.”

    Animalsmouse challenge models of influenza A (H1N1 or highly pathogenic H5N1) and influenza Bliposomally encapsulated cGAMP

    Therapeutic intranasal delivery of NanoSTING provides broad protection against seasonal and highly pathogenic influenza strains

    Antiviral research

More on Influenza

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 3Sep 2026: 0Oct 2026: 1Nov 2026: 312 papers in 12 months
Cellular & Molecular Biology Letters

Blocking an ion channel reduced cartilage damage in mice

Experiments in mice with osteoarthritis found that inhibiting or removing the channel also reduced bone hardening and senescence, a state in which cartilage cells stop…Experiments in mice with osteoarthritis found that inhibiting or removing the channel also reduced bone hardening and senescence, a state in which cartilage cells stop dividing.

Mouse studyBones and joints
Free Radical Biology & Medicine

Gene variant linked to greater brain inflammation in aging mice

Experiments in mice aged 4, 12 and 20 months linked a human gene variant to greater buildup of sugar-modified molecules and inflammatory signaling.Experiments in mice aged 4, 12 and 20 months linked a human gene variant to greater buildup of sugar-modified molecules and inflammatory signaling.

Mouse studyInflammation

See all 40 papers on cgamp